2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgerySigrun Halvorsen, Volkmar Falk, Tobias Geisler et al.|European Heart Journal|2022Cited by 1.1k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A. Voors, Piotr Ponikowski, Christiane E. Angermann et al.|Nature Medicine|2022Cited by 889
Beta-Blockers after Myocardial Infarction in Patients without Heart FailureJohn Munkhaugen, Gro Egholm, Anna Meta Dyrvig Kristensen et al.|New England Journal of Medicine|2025Cited by 73
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point studyJohn Munkhaugen, Dan Atar, Vidar Ruddox et al.|American Heart Journal|2018Cited by 50